Drug Shortage Report for TEVA-TECNAL C 1/2
Report ID | 222560 |
Drug Identification Number | 00608181 |
Brand name | TEVA-TECNAL C 1/2 |
Common or Proper name | TECNAL C-1/2 CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CODEINE PHOSPHATE ACETYLSALICYLIC ACID CAFFEINE BUTALBITAL |
Strength(s) | 30MG 330MG 40MG 50MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-03-10 |
Estimated end date | 2024-06-10 |
Actual end date | 2024-05-08 |
Shortage status | Resolved |
Updated date | 2024-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-05-09 | French | Compare |
v5 | 2024-05-09 | English | Compare |
v4 | 2024-05-03 | French | Compare |
v3 | 2024-05-03 | English | Compare |
v2 | 2024-03-18 | French | Compare |
v1 | 2024-03-18 | English | Compare |
Showing 1 to 6 of 6